Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Settings
MRK [NYSE]
Merck & Co. Inc.
IndexDJIA S&P500 P/E15.51 EPS (ttm)3.85 Insider Own0.04% Shs Outstand2.83B Perf Week-1.26%
Market Cap168.67B Forward P/E15.67 EPS next Y3.81 Insider Trans-36.39% Shs Float2.82B Perf Month-0.47%
Income11.17B PEG3.54 EPS next Q0.80 Inst Own75.40% Short Float1.11% Perf Quarter2.07%
Sales41.40B P/S4.07 EPS this Y176.90% Inst Trans-0.47% Short Ratio2.78 Perf Half Y2.34%
Book/sh16.85 P/B3.54 EPS next Y10.72% ROA11.00% Target Price65.75 Perf Year9.11%
Cash/sh5.52 P/C10.81 EPS next 5Y4.39% ROE23.50% 52W Range51.68 - 63.11 Perf YTD5.97%
Dividend1.80 P/FCF128.95 EPS past 5Y-6.30% ROI0.50% 52W High-5.40% Beta0.32
Dividend %3.02% Quick Ratio1.30 Sales past 5Y9.00% Gross Margin61.40% 52W Low15.52% ATR0.81
Employees70000 Current Ratio1.60 Sales Q/Q-8.20% Oper. Margin37.70% RSI (14)51.68 Volatility1.15% 1.23%
OptionableYes Debt/Eq0.63 EPS Q/Q-42.10% Profit Margin27.00% Rel Volume0.84 Prev Close59.46
ShortableYes LT Debt/Eq0.53 EarningsApr 28 BMO Payout45.30% Avg Volume11.32M Price59.70
Recom2.40 SMA20-0.42% SMA501.88% SMA2002.24% Volume9,525,696 Change0.40%
Apr-29-15Reiterated UBS Buy $64 → $68
Apr-29-15Reiterated Argus Buy $66 → $70
Apr-30-14Reiterated Argus Buy $62 → $66
Apr-11-14Reiterated MKM Partners Buy $64 → $70
Feb-05-14Reiterated Argus Buy $54 → $62
Jan-14-14Reiterated MKM Partners Buy $59 → $64
Jun-03-13Reiterated MKM Partners Buy $54 → $59
Apr-15-13Reiterated Barclays Overweight $45 → $60
Feb-04-13Reiterated MKM Partners Buy $51 → $52
Feb-04-13Reiterated Barclays Overweight $46 → $45
Nov-20-12Upgrade MKM Partners Neutral → Buy $47 → $51
Oct-17-12Reiterated MP Advisors Outperform $45 → $50
Jul-30-12Reiterated UBS Buy $45 → $50
Jul-13-12Upgrade MP Advisors Market Perform → Outperform $45
Feb-03-12Reiterated Barclays Capital Overweight $38 → $40
Feb-03-12Downgrade MKM Partners Buy → Neutral $42 → $40
Nov-29-11Initiated MKM Partners Buy $38
Sep-14-11Reiterated Barclays Capital Overweight $41 → $38
May-16-11Reiterated UBS Buy $40 → $42
Feb-04-11Reiterated UBS Buy $42 → $40
May-28-15 05:39PM  Merck Files New Drug Application for Hepatitis Combination at The Wall Street Journal
04:41PM  MERCK & CO., INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
04:30PM  Merck Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investigational Once-Daily, Single Tablet Combination Therapy, for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection Business Wire
03:10PM  Can Cancer Killers Lift Bristol-Myers, Merck? at Barrons.com
09:30AM  Short Sellers More Selective on Big Pharma Stocks at 24/7 Wall St.
08:30AM  Merck and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDA® (pembrolizumab) Business Wire
07:00AM  Merck Serono as Pioneer in Assisted Reproductive Treatments Takes Leading Role in Fertility Technologies Signing a Global Collaboration Agreement with Genea Biomedx CNW Group
May-27-15 04:30PM  Merck/J&J Get CHMP Backing for Simponi's Expanded Use - Analyst Blog
01:01PM  Two parts of Express Scripts' new plan
10:22AM  One trader's very contrarian pharma trade at CNBC
May-26-15 02:15PM  Merck's (MRK) Keytruda a Step Closer to European Approval - Analyst Blog
01:31PM  Merck Announces Third-Quarter 2015 Dividend Business Wire
06:33AM  SIMPONI® (golimumab) Gains Positive Opinion from Committee for Medicinal Products for Human Use (CHMP) for the Treatment of Non-Radiographic Axial Spondyloarthritis PR Newswire
01:48AM  Pharma Trumps All Healthcare Sectors In Executive Compensation at Forbes
01:00AM  Merck Serono Supports 7th International Thyroid Awareness Week to Unmask Hypothyroidism CNW Group
May-23-15 07:07AM  Germany's Merck expects drug division to drive growth-Euro am Sonntag
May-22-15 01:57PM  Expert Explains How To Play Merck In 2 Charts
01:31PM  Merck KGaA Making Over Ambitious Growth Plans For Future?
07:22AM  Merck follows Bristol with EU green light for immune cancer drug Reuters
07:12AM  MSD Receives Positive CHMP Opinion for Pembrolizumab for the Treatment of Advanced Melanoma Business Wire
07:12AM  Merck Receives Positive CHMP Opinion for KEYTRUDA® (pembrolizumab) for the Treatment of Advanced Melanoma Business Wire
01:00AM  U.S. bird flu causing egg squeeze, emergency measures
May-21-15 08:47AM  3 Big Pharmaceutical Stocks to Buy Right Now at TheStreet
May-20-15 12:18AM  [$$] Merck Could Struggle to Hit Health Care Heights at The Wall Street Journal
May-19-15 04:21PM  Healthcare Winners and Losers: May 19, 2015
03:15PM  Merck KGaA profits decline on Sigma-Aldrich acquisition costs at bizjournals.com
10:26AM  Merck Could Struggle to Hit Health Care Heights at The Wall Street Journal
10:10AM  Merck KGaA Q1 Earnings Fall Y/Y, 2015 Sales View Retained - Analyst Blog
09:17AM  Pharmalot Pharmalittle Good Morning: We're Catching Up on Endo, J&J, Merck and More . . . at The Wall Street Journal
May-18-15 08:00AM  Merck to Present at the UBS Global Healthcare Conference Business Wire
May-17-15 11:11PM  China's JD.com in online pharmacy tie-up with Shanghai Pharma
May-15-15 08:36AM  Indian court bars Glenmark from selling Merck drug copies Reuters
06:48AM  India's Supreme Court bars Glenmark from selling copies of Merck diabetes drugs-sources
May-14-15 11:50PM  The drugs to watch in fight against cancer at Financial Times
12:59PM  Puma Crashes, Roche Rises On Cancer Data News at Investor's Business Daily
06:19AM  ASCO's immunotherapies update
May-13-15 05:53PM  10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15 at TheStreet
05:40PM  Biotech goldmine
05:00PM  2015 ASCO Annual Meeting: New Data in 10 Different Cancers from Mercks Rapidly Expanding Immuno-Oncology Research Program for KEYTRUDA® (pembrolizumab) to be Presented Business Wire
02:36PM  Biotech to watch ahead of ASCO
02:01PM  Pay attention to bonds
01:04PM  MERCK & CO., INC. Financials
11:53AM  Biotech investors: These are the key names to know at CNBC
10:13AM  Llama-Based Biotechnology Draws New Interest to Ablynx at Bloomberg
12:15AM  [$$] Overheard: Monsantos Rivals Could Be Help for Syngenta at The Wall Street Journal
May-12-15 04:24PM  Monsanto's Rivals Could Be Help for Syngenta -- Overheard at The Wall Street Journal
12:26PM  Threshold Pharmaceuticals (THLD) Stock Soars on FDA Fast Track Designation at TheStreet
10:18AM  Bavarian Nordic gets 50 million euro EIB loan for Ebola vaccine Reuters
09:50AM  Short Sellers Keep Strong Bets Against Big Pharma at 24/7 Wall St.
09:15AM  Mega-Caps Posted the Biggest Earnings Surprises: 4 to Buy Now at 24/7 Wall St.
08:28AM  As Ebola disappears, no useful data seen from vaccine trials -WHO
07:00AM  Move Over, Elon Musk: CNBC's No. 1 Disruptor This Year Is A Biotech Company, Moderna at Forbes
07:00AM  A hot biotech that may be the next Genentech at CNBC
May-11-15 10:49AM  Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Citigroup Inc (C) Top Kahn Brothers Portfolio at Insider Monkey
May-08-15 09:20AM  4 Pharmaceutical Companies Leading the Breast Cancer Fight at 24/7 Wall St.
08:05AM  Measles Vaccine Reduces Death From Other Infections Too -- By Preventing 'Immune Amnesia' at Forbes
May-07-15 04:58PM  MERCK & CO., INC. Files SEC form 10-Q, Quarterly Report
04:50PM  Prescription Fish Oil Maker Hires Top Lawyer To Sue FDA On First Amendment Grounds at Forbes
09:07AM  Plexxikon and Merck to Collaborate on Combination Study Evaluating Investigational Immuno-oncology Regimen at noodls
08:43AM  Sigma-Aldrich (SIAL) Misses Q1 Earnings and Revenue Estimates - Tale of the Tape
07:05AM  The Smartphone In Your Pocket Could Help Treat River Blindness For Millions at Forbes
05:05AM  Merck Presents Organic Photovoltaic Materials at EXPO 2015 in Milan at noodls
May-06-15 06:13PM  Merck's Stock Price, Dividend Yield Beating S&P 500 at Investor's Business Daily
03:14PM  Everything you need to know about the $8.4B acquisition of Synageva at bizjournals.com
10:00AM  Big Pharma Q1 Earnings Beat Put Pharma ETFs in Focus - ETF News And Commentary
05:16AM  Study Finds Merck Millipores Strat-M® Synthetic Membrane Comparable to Human and Animal Skin for Permeation Studies at noodls
May-05-15 12:46PM  Healthcare Mid-Day Winners and Losers: May 04, 2015
12:46PM  Healthcare Winners and Losers: May 04, 2015
10:50AM  Top Credit Suisse Major Pharma Stock Picks to Buy at 24/7 Wall St.
08:51AM  Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers
07:02AM  The Cancer Drug Market Just Hit $100 Billion And Could Jump 50% In Four Years at Forbes
02:45AM  Global cancer drug spending hits $100 billion in 2014-IMS Health Reuters
May-04-15 07:24PM  Vanguard Adds to Four of Its Largest Stakes
04:01PM  The 4 Stocks That Buoyed the Dow on Monday at 24/7 Wall St.
01:06PM  Murky Situation Over the Merck Name Plagues Two Drug Makers at The Wall Street Journal
08:02AM  Weak Q1 Earnings Have Some Investors Worried.......Should You Be?
May-03-15 08:23AM  A tale of two Mercks: Confusion mounts over shared brand name at Financial Times
07:00AM  The Advantages of Owning Individual Stocks at Morningstar
May-01-15 02:38PM  Top picks in health care
01:20PM  Business events scheduled for the coming week
12:29PM  Gilead Soothes Price War Worry With Q1 Results
08:46AM  Bank Of America Reviews Gilead Earnings
Apr-30-15 11:20AM  Merck deal boosts sales but not income at Bayer at bizjournals.com
11:19AM  Is a choice between Apple and Merck stock that obvious? at MarketWatch
05:31AM  Rubella Eliminated From The Americas, Thanks To MMR Vaccine at Forbes
03:11AM  Paul T. Anastas Awarded Emanuel Merck Lectureship 2015 at noodls
01:38AM  Bayer First-Quarter Profit Rises on Xarelto, Merck Acquisition at Bloomberg
Apr-29-15 05:05PM  FDA Panel Gives Thumbs-Up To Amgen's Virus-Based Melanoma Drug at Forbes
04:15PM  Merck & Co. (MRK) Earnings Analysis: By the Numbers
03:44PM  Pfizer (PFE) Earnings Analysis: By the Numbers
03:34PM  Januvia Passes, Afrezza On Deck at Forbes
03:23PM  Bristol-Myers Squibb (BMY) Earnings Analysis: By the Numbers
03:23PM  EU Needs New Drugs to Fight Antibiotic Resistance at Barrons.com
12:34PM  What's Wall Street Been Saying About Gilead Lately?
10:52AM  April US Consumer Confidence Dips to 95.2 on Rising Fuel Costs
07:00AM  This Pharma Firm Passes the Test at Morningstar
06:00AM  Investors on Fed statement, first-quarter GDP watch at CNBC
12:21AM  Pfizer, Merck and Bristol-Myers Squibb Report Solid Results at The Wall Street Journal
12:20AM  Mercks Shrinking Revenue Doesnt Fit Its Stock at The Wall Street Journal
12:19AM  HCL celebrates 10 years of successful engagement with Merck at noodls
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents for use in surgery; anti-bacterial products for skin and skin structure infections; antidepressants; ophthalmic and cholesterol modification products; non-sedating antihistamine; and vaginal contraceptive implants. In addition, the company provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; to treat brain tumors and melanoma; to prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers animal health products, including antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics for, and vaccines against bacterial and viral disease in fish. Additionally, the company provides companion animal products, such as diabetes mellitus treatment drugs and vaccines for dogs and cats; ointments for acute and chronic otitis; anthelmintic products; chewable tablets to kill fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. The company serves drug wholesalers and retailers, hospitals, government entities and agencies, physicians, physician distributors, veterinarians, distributors, and animal producers, as well as managed health care providers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schechter Adam HEVP & Pres-Global Human HealthMay 11Sale60.4410,634642,7680May 11 05:48 PM
Gerberding Julie L.EVP Strat Comm, Gl Pub PolicyMay 08Option Exercise35.2846,2081,630,39670,353May 11 01:33 PM
Gerberding Julie L.EVP Strat Comm, Gl Pub PolicyMay 08Sale60.9938,3682,339,94931,985May 11 01:33 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Option Exercise39.2956,0642,202,755206,496May 05 04:46 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Sale60.2056,0643,374,795150,432May 05 04:46 PM
Gerberding Julie L.EVP Strat Comm, Gl Pub PolicyMay 02Option Exercise0.003,818025,359May 05 04:46 PM
Golestani ClarkEVP & Chief Info OfficerMay 02Option Exercise0.002,291010,259May 05 04:46 PM
GRADDICK WEIR MIRIAN MExe V-P, HRMay 02Option Exercise0.008,6540116,334May 05 04:46 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 02Option Exercise0.004,709015,129May 05 04:46 PM
Rosenblatt MichaelExec V-P & Chief Med OfficerMay 02Option Exercise0.003,818034,534May 05 04:46 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 02Option Exercise0.0019,343019,343May 05 04:46 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 02Option Exercise0.0011,7080156,503May 05 04:46 PM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerMay 02Option Exercise0.003,818020,794May 05 04:46 PM
Deese Willie AExe V-P & Pres. MMDMay 02Option Exercise0.007,6360122,631May 05 04:46 PM
DeLuca Richard R.EVP&Pres, Merck Animal HealthMay 02Option Exercise0.005,090014,564May 05 04:46 PM
Holston Michael JEVP, LegalApr 29Option Exercise44.39135,6246,020,460135,624Apr 29 06:01 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 29Option Exercise38.51156,9026,042,441301,697Apr 29 06:01 PM
Holston Michael JEVP, LegalApr 29Sale59.8495,6245,722,54240,000Apr 29 06:01 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 29Sale59.82156,9029,386,646144,795Apr 29 06:01 PM
HARRISON WILLIAM B JRDirectorApr 13Option Exercise33.835,000169,15011,400Apr 13 05:24 PM
FRAZIER KENNETH CChairman, President & CEOFeb 18Option Exercise31.847,082225,491358,564Feb 18 04:51 PM
FRAZIER KENNETH CChairman, President & CEOFeb 18Sale58.675,164302,959353,400Feb 18 04:51 PM
Deese Willie AExe V-P & Pres. MMDFeb 11Option Exercise40.44135,8645,494,524242,094Feb 11 02:19 PM
Deese Willie AExe V-P & Pres. MMDFeb 11Sale58.56135,8647,956,372106,230Feb 11 02:19 PM
WENDELL PETER CDirectorFeb 09Option Exercise33.835,000169,1506,000Feb 09 03:24 PM
WENDELL PETER CDirectorFeb 09Sale58.765,000293,7971,000Feb 09 03:24 PM
Schechter Adam HEVP & Pres-Global Human HealthJan 15Option Exercise41.1874,2003,055,57874,200Jan 15 03:55 PM
Schechter Adam HEVP & Pres-Global Human HealthJan 15Sale62.4874,2004,636,2240Jan 15 03:55 PM
FRAZIER KENNETH CChairman, President & CEOJan 09Option Exercise34.2012,874440,240360,322Jan 09 02:44 PM
FRAZIER KENNETH CChairman, President & CEOJan 09Sale62.478,840552,267351,482Jan 09 02:44 PM
FRAZIER KENNETH CChairman, President & CEODec 10Option Exercise34.2012,874440,240357,294Dec 10 05:59 PM
FRAZIER KENNETH CChairman, President & CEODec 10Sale60.009,846590,760347,448Dec 10 05:59 PM
Kuhlik Bruce NExe V-P & Gen CounselDec 08Option Exercise51.0250,0002,551,000178,467Dec 08 06:55 PM
Kuhlik Bruce NExe V-P & Gen CounselDec 08Sale62.0050,0003,100,000128,467Dec 08 06:55 PM
LAZARUS ROCHELLE BDirectorNov 26Option Exercise34.1410,000341,35014,595Nov 26 12:40 PM
LAZARUS ROCHELLE BDirectorNov 26Sale59.6310,000596,3004,595Nov 26 12:40 PM
WEEKS WENDELL PDirectorNov 24Option Exercise33.835,000169,1505,100Nov 25 07:08 PM
WEEKS WENDELL PDirectorNov 24Sale59.135,000295,663100Nov 25 07:08 PM
FRAZIER KENNETH CChairman, President & CEONov 10Option Exercise34.2012,875440,272354,420Nov 10 04:36 PM
FRAZIER KENNETH CChairman, President & CEONov 10Sale57.9810,000579,784344,420Nov 10 04:36 PM
DeLuca Richard R.EVP&Pres, Merck Animal HealthNov 02Option Exercise0.004,38704,387Nov 03 04:46 PM
FRAZIER KENNETH CChairman, President & CEOOct 10Option Exercise34.2012,875440,272351,440Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOOct 10Sale59.739,895591,033341,545Oct 14 09:05 AM
FRAZIER KENNETH CChairman, President & CEOSep 10Option Exercise34.2012,875440,272348,379Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOSep 10Sale60.489,814593,592338,565Sep 10 01:53 PM
FRAZIER KENNETH CChairman, President & CEOAug 11Option Exercise34.2012,875440,272345,562Aug 12 09:01 AM
FRAZIER KENNETH CChairman, President & CEOAug 11Sale57.0010,058573,306335,504Aug 12 09:01 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Option Exercise45.3823,4001,061,82042,844Aug 05 09:56 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Sale56.6428,6691,623,72014,175Aug 05 09:56 AM
REPRESAS CARLOS EDirectorAug 01Option Exercise35.195,000175,9505,500Aug 05 10:16 AM
FRAZIER KENNETH CChairman, President & CEOJul 10Option Exercise34.2012,876440,307351,474Jul 10 03:47 PM
FRAZIER KENNETH CChairman, President & CEOJul 10Sale58.039,987579,545341,487Jul 10 03:47 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Option Exercise30.01180,0475,403,278273,611Jul 08 02:16 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Sale59.16180,04710,650,93293,564Jul 08 02:16 PM
Deese Willie AExe V-P & Pres. MMDJun 27Option Exercise27.8572,2902,013,164178,512Jun 30 04:23 PM
Deese Willie AExe V-P & Pres. MMDJun 27Sale58.2672,2904,211,254106,222Jun 30 04:23 PM